Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRINITY: Immunosuppression in Inflammatory Cardiomyopathy
NCT05570409Phase 3Terminated
- Sponsor
- LMU Klinikum
- Start
- Mar 2023
- Primary completion
- Apr 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of mycophenolate mofetil, prednisolone in inflammatory cardiomyopathy, sponsored by LMU Klinikum. Started Mar 2023; status: terminated.
02
Drugs
mycophenolate mofetilprednisolone
03
Conditions
inflammatory cardiomyopathy
Beyond the preview
Go deeper on NCT05570409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05570409.